CRISPRi/a screens in human iPSC-cardiomyocytes identify glycolytic activation as a druggable target for doxorubicin-induced cardiotoxicity
Chunying Liu(Medical College of Wisconsin), Joseph C. Wu(Cardiovascular Institute of the South)
Cited by 35
Related Papers
COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives
|Nature Reviews Cardiology|2020|1.5k
A Premature Termination Codon Mutation in MYBPC3 Causes Hypertrophic Cardiomyopathy via Chronic Activation of Nonsense-Mediated Decay
|Circulation|2019|124
Statins improve endothelial function via suppression of epigenetic-driven EndMT
|Nature Cardiovascular Research|2023|73